DCP Capital Expands Global Footprint with Cargill Protein China Acquisition

DCP Capital is making waves in the investment world, and its latest move is a big one. DCP Capital Expands Global Footprint with Cargill Protein China Acquisition.

The acquisition is a significant step in DCP Capital's growth strategy, and it's clear that the company is committed to expanding its global reach. DCP Capital is a leading investment firm that has been making strategic investments in various industries.

With this acquisition, DCP Capital is now a major player in the protein industry in China, and it's likely to have a significant impact on the market. The acquisition is a testament to DCP Capital's ability to identify and capitalize on opportunities in emerging markets.

Expand your knowledge: B Capital

DCP Capital has been quite active in the last 3 years, having acquired 1 company.

The firm's investment focus is mainly on two sectors: food and life science, which account for 27% and 20% of its investments respectively.

Growth capital and stake purchase are the most common investment types for DCP Capital, making up 34% and 27% of its investments.

In terms of geography, DCP Capital has invested in 1 US state and 3 different countries.

Its largest disclosed acquisition was a $5.7B deal in 2021, where it acquired 51job.

DCP Capital has successfully exited 1 company in the last 3 years.

DCP Capital has a significant presence in the private equity industry, with a focus on growth equity investments in Asia.

The firm's investments are primarily concentrated in the consumer and retail, healthcare, and technology sectors.

DCP Capital has a strong track record of identifying and investing in high-growth companies, with a focus on supporting their expansion and development.

Explore further: What Is Capital Investments

DCP Capital has acquired Cargill Protein China, a significant move in the poultry business in China. Cargill Protein China includes farms and related manufacturing sites in Chuzhou in the Anhui province.

The deal was designed to support the continued operation of the business in China and sustain access for customers to Cargill's high-quality products and services. Cargill has operated in China for over 50 years and will continue to evolve to best serve the growing domestic food and agricultural markets.

Cargill invested nearly $50 million to launch an integrated poultry production plant in Chuzhou in 2019. This investment enabled the company to slaughter almost 50 million broilers per year through its operations in the country.

The transaction is subject to regulatory approvals and is expected to close this year. Once completed, DCP Capital will work to grow the business, stated Cargill.

DCP Capital Partners, a Beijing-based private equity firm, is in talks to acquire a leading maternity and pediatric care hospital chain in China.

Meihua Hospital, also known as American-Sino OB/GYN/Pediatrics Services, could be valued at around $400 million to $500 million in a sale.

Discussions are ongoing and may not lead to a transaction.

Meihua Hospital was set up in 2003 to provide women and children’s health care services in Shanghai.

It now serves over 80,000 people each year with more than 400 physicians and nurses.

The hospital has facilities in Shanghai, Beijing, and Hangzhou.

China is aging more quickly than most developed economies, and this deal could be part of the country's efforts to ease birth restrictions.

DCP Capital has made some impressive deals over the years. In August 2018, the company joined an investor consortium led by Hillhouse Capital to acquire Yum China for $13 billion, but the deal fell through after Yum China rejected the offer.

This was a significant attempt, but it ultimately didn't come to fruition. In March 2022, DCP Capital successfully acquired 51job, a China-based jobs portal listed on the Nasdaq, for $4.3 billion.

DCP Capital also acquired a minority interest in the Chinese operations of Jamieson Wellness, a Canadian multinational pharmaceutical company, in February 2023. The company paid $35 million for 33.3% of the Chinese business and subscribed for $75 million of preferred shares of Jamieson Wellness.

Other notable acquisitions include the purchase of Cargill's China poultry unit in May 2023, and the majority stake in supermarket chain Sun Art Retail Group from Alibaba Group in January 2025 for HK$12.298 billion ($1.58 billion).

Here are some of the notable deals made by DCP Capital: